Evidence map›Paper›PMID 36864749›Full record

ArticleNucleic acids research2023

SpliceTools, a suite of downstream RNA splicing analysis tools to investigate mechanisms and impact of alternative splicing.

Erik K Flemington, Samuel A Flemington, Tina M O'Grady, Melody Baddoo, Trang Nguyen, Yan Dong, Nathan A Ungerleider

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Bioinformatics advances · 2024
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Erik K FlemingtonDepartment of Pathology, Tulane University, New Orleans, LA, USA.ORCID 0000-0003-0513-5281
Samuel A FlemingtonTulane Cancer Center, Tulane University, New Orleans, LA, USA.
Tina M O'GradyDepartment of Pathology, Tulane University, New Orleans, LA, USA.ORCID 0000-0002-1283-0293
Melody BaddooDepartment of Pathology, Tulane University, New Orleans, LA, USA.
Trang NguyenDepartment of Pathology, Tulane University, New Orleans, LA, USA.
Yan DongDepartment of Structural and Cellular Biology, Tulane University, New Orleans, LA, USA.ORCID 0000-0003-1622-5354
Nathan A UngerleiderDepartment of Pathology, Tulane University, New Orleans, LA, USA.
Tulane University · US

Funding

"Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesisP01CA214091 · NCI · UNIVERSITY OF FLORIDA · PI Scott A. Tibbetts · 2017 to 2026
$15.9M
Programmed splicing derangement as new EBV host cell shut-off mechanismR01CA262090 · NCI · WAYNE STATE UNIVERSITY · PI ERIK K FLEMINGTON · 2022 to 2026
$2.1M
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interferenceR01CA272142 · NCI · WAYNE STATE UNIVERSITY · PI ERIK K FLEMINGTON · 2022 to 2026
$2.1M
RPMS1 circular RNAs in EBV malignanciesR01CA243793 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2019 to 2023
$1.8M
NCI NIH HHS P01 CA214091NCI NIH HHS R01 CA243793NCI NIH HHS R01 CA262090NCI NIH HHS R01 CA272142
6 · The paper itself

Abstract

As a fundamental aspect of normal cell signaling and disease states, there is great interest in determining alternative splicing (AS) changes in physiologic, pathologic, and pharmacologic settings. High throughput RNA sequencing and specialized software to detect AS has greatly enhanced our ability to determine transcriptome-wide splicing changes. Despite the richness of this data, deriving meaning from sometimes thousands of AS events is a substantial bottleneck for most investigators. We present SpliceTools, a suite of data processing modules that arms investigators with the ability to quickly produce summary statistics, mechanistic insights, and functional significance of AS changes through command line or through an online user interface. Utilizing RNA-seq datasets for 186 RNA binding protein knockdowns, nonsense mediated RNA decay inhibition, and pharmacologic splicing inhibition, we illustrate the utility of SpliceTools to distinguish splicing disruption from regulated transcript isoform changes, we show the broad transcriptome footprint of the pharmacologic splicing inhibitor, indisulam, we illustrate the utility in uncovering mechanistic underpinnings of splicing inhibition, we identify predicted neo-epitopes in pharmacologic splicing inhibition, and we show the impact of splicing alterations induced by indisulam on cell cycle progression. Together, SpliceTools puts rapid and easy downstream analysis at the fingertips of any investigator studying AS.

Indexed as

Alternative SplicingRNA SplicingSequence Analysis, RNASulfonamidesTranscriptomeN-(3-chloro-7-indolyl)-1,4-benzenedisulphonamideSulfonamides

Identifiers

PMID36864749
PMCPMC10123099
OpenAlexW4323036862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.